A Study to See if an Investigational Medicine Called VS-01 Can Help and How Safe it is in the Treatment of Patients With Overt Hepatic Encephalopathy

NCT06987968 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Hepatic Encephalopathy
Acute on Chronic Liver Failure (ACLF)
Decompensated Cirrhosis

Interventions

DRUG: VS-01 on top of SOC (Active Treatment Group)
DRUG: SOC

Sponsor

Genfit